Nursing homes still miss inspections amid pandemic To view this email as a web page,
click here Pfizer, Moderna hike COVID-19 vaccine prices in new European supply deals: report Majority of nursing homes missing broad safety, quality inspections due to the pandemic COVID-19 tracker: Germany, Britain to offer boosters next month to some; J&J reportedly pulls vaccine application in India Going to HIMSS21 in Vegas? Here's what you need to know Featured Story | By Fraiser Kansteiner In the pandemic's second year, Pfizer and Moderna's mRNA vaccines largely reign supreme. In new European purchase agreements, the companies are charging more for their doses, The Financial Times reports. read more |
| |
|---|
|
Top Stories By Anastassia Gliadkovskaya A new report finds that 71% of nursing homes have been without certain CMS-mandated inspections for longer than required due to the coronavirus pandemic. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner Germany and Britain will reportedly offer vaccine boosters beginning in September amid the rapid spread of the Delta variant. Johnson & Johnson pulled its application seeking accelerated approval for local vaccine trials in India, according to reports. And more headlines. read more By Heather Landi HIMSS21 will kick off one week from today in Las Vegas as the first and largest on-site healthcare conference since the start of the COVID-19 pandemic last spring. As the conference approaches, the state of Nevada is seeing a surge in cases. Here's what you need to know. read more |
|
